MRC Biostatistics UnitThe MRC Biostatistics are pleased to announce we will be holding a 2 day workshop on
“Clinical trials in the era of precision medicine: new developments”
Dates- 26th-27th March 2020
Location- Cambridge, UK
Precision medicine has the aim of determining which patients benefit from which treatment. Clinical trials have an important role in gathering robust evidence for enabling precision medicine. This workshop will showcase new developments in the design, conduct and analysis of precision medicine trials, including:
- Innovative Trial designs for precision medicine
- Methods for conducting efficient and complex trials
- Statistical analysis issues
- Communicating and reporting results from precision medicine trials
- Precision medicine for rare disease
- Precision medicine for non-drug interventions
Speakers:
Dr Jean Abraham, University of Cambridge
Dr Rowena Sharpe, University of Birmingham
Dr Rebecca Turner, MRC Clinical Trials Unit at UCL
Professor Ian White, MRC Clinical Trials Unit at UCL
Dr Haiyan Zheng, Newcastle University
Professor James Wason, MRC Biostatistics Unit and Newcastle University
Professor Christina Yap, Institute of Cancer Research
Professor Jack Bowden, University of Exeter
Professor Kit Roes, Radboud University, The Netherlands
The event will consist of invited speakers from the UK and beyond as well as contributed talks. It will take place in the same week as a parallel two-day course run at the MRC Biostatistics Unit on ‘Statistical methods for design and analysis of precision medicine trials’.
We invite you to submit an abstract for a contributed talk or poster via the following link –Abstract submission form, please note the closing date for abstracts is 31st January 2020.
To register: click here